Table 3.
Surgical outcomes
| Variables | Intracorporeal (n = 35) | Extracorporeal (n = 125) | P value |
|---|---|---|---|
| Pathological tumor stage (n [%]) | |||
| T | 0.160 | ||
| T1 | 3 (8.57%) | 15 (12.00%) | |
| T2 | 7 (20%) | 12 (9.60%) | |
| T3 | 8 (22.58%) | 18 (14.40%) | |
| T4 | 17 (48.57%) | 80 (64.00%) | |
| N | 0.889 | ||
| N0 | 13 (37.14%) | 41 (32.80%) | |
| N1 | 5 (14.29%) | 21 (16.80%) | |
| N2 | 7 (20.00%) | 21 (16.80%) | |
| N3 | 10 (28.57%) | 42 (33.60%) | |
| M | 1.000 | ||
| M0 | 35 (100.00%) | 124 (99.20%) | |
| M1 | 0 (0.00%) | 1 (0.80%) | |
| Stage ([%]) | 0.690 | ||
| I | 8 (22.86%) | 21 (16.80%) | |
| II | 9 (25.71%) | 29 (23.20%) | |
| III | 18 (51.43%) | 74 (59.20%) | |
| IV | 0 (0.00%) | 1 (0.80%) | |
| ([%]) | 0.981 | ||
| Yes | 18 (51.43%) | 64 (51.20%) | |
| No | 17 (48.57%) | 61 (48.80%) | |
| Vessel carcinoma embolus (n [%]) | 0.217 | ||
| Yes | 10 (28.57%) | 50 (40%) | |
| No | 25 (71.43%) | 75 (60%) | |
| Number of lymph nodes (Mean ± SD) | 26.17 ± 9.718 | 23.88 ± 9.860 | 0.225 |
| Number of positive lymph nodes (Mean ± SD) | 4.71 ± 6.114 | 6.39 ± 9.067 | 0.305 |